×
About 545 results

ALLMedicine™ AA Amyloidosis Center

Research & Reviews  200 results

Schnitzler Syndrome Clinical Presentation
http://emedicine.medscape.com/article/1050761-clinical

Feb 2nd, 2023 - History All patients with Schnitzler syndrome present with a chronic, recurrent, urticarial eruption. Pruritus is usually absent at the disease onset, but lesions may become mildly pruritic in approximately 45% of patients after 3-4 years. The ski...

Pathological spectrum of hereditary transthyretin renal amyloidosis and clinicopatholog...
https://doi.org/10.1093/ndt/gfad006
Nephrology, Dialysis, Transplantation : Official Publicat... Dang J, Ferlicot S et. al.

Jan 17th, 2023 - Cardiac and neurological involvements are the main clinical features of hereditary transthyretin (ATTRv) amyloidosis. Few data are available about ATTRv amyloid nephropathy (ATTRvN). We retrospectively included 30 patients with biopsy-proven ATTRv...

Long-term results of kidney transplantation in patients with familial mediterranean fever.
https://doi.org/10.1111/ctr.14888
Clinical Transplantation; Bitik B, Hatipoğlu B et. al.

Dec 23rd, 2022 - Long-term kidney transplantation (KT) results in patients with familial Mediterranean fever (FMF)-related amyloidosis are not well studied. This study reviewed the long-term survival outcomes of FMF patients who underwent KT. We compared the outco...

Efficacy and safety of interleukin-1 blockers in kidney transplant recipients with fami...
https://doi.org/10.1093/ndt/gfac335
Nephrology, Dialysis, Transplantation : Official Publicat... Mirioglu S, Dirim AB et. al.

Dec 22nd, 2022 - Data on use of IL-1 blockers in kidney transplant recipients (KTRs) with familial Mediterranean fever (FMF) are very limited. We aimed to evaluate the efficacy and safety of anakinra and canakinumab in the transplantation setting. In this retrospe...

AA (Inflammatory) Amyloidosis
http://emedicine.medscape.com/article/335559-overview

Dec 19th, 2022 - Practice Essentials Amyloidosis comprises a heterogeneous group of diseases in which normally soluble plasma proteins are deposited in the extracellular space in an abnormal, insoluble, fibrillar form. Amyloid A (AA) amyloidosis, previously known ...

see more →

Clinicaltrials.gov  8 results

Registre HEAR, Healthcare European Amyloidosis Registry
https://clinicaltrials.gov/ct2/show/NCT05101304

Nov 1st, 2021 - Amyloidosis is a rare disease characterized by infiltration and continuous accumulation of insoluble fibrillar proteins in the extracellular matrix in various organs including kidney, nerve, liver, heart and skeletal muscle. Its prevalence is esti...

Renal Manifestations of IBD
https://clinicaltrials.gov/ct2/show/NCT04301297

Jan 28th, 2021 - Inflammatory bowel diseases (IBD) comprise two types of chronic intestinal disorders: Crohn's disease (CD) and ulcerative colitis (UC). CD involves the ileum and colon, but it can affect any region of the intestine, often discontinuously. UC invol...

Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies
https://clinicaltrials.gov/ct2/show/NCT04702932

Jan 11th, 2021 - Auto-inflammatory Diseases (AIDs) are defined by disorders of the innate immunity. They manifest themselves as episodes of inflammation associated with general signs and organ damage, mainly to the cutaneous, musculoskeletal and digestive systems....

Recurrent AA Amyloidosis After Renal Transplantation
https://clinicaltrials.gov/ct2/show/NCT02704065

Apr 18th, 2017 - AA amyloidosis is a rare but serious complication of several chronic inflammatory diseases including recurrent hereditary periodic fever syndromes. Although end-stage renal disease related to AA amyloidosis is well characterized, there is limited ...

Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
https://clinicaltrials.gov/ct2/show/NCT01215747

Mar 10th, 2016 - The primary purpose of this study is to assess the efficacy and safety of treatment with Kiacta in adult patients with AA Amyloidosis.

see more →

News  5 results

Fast Five Quiz: How Much Do You Know About Amyloidosis?
https://reference.medscape.com/viewarticle/903213_3

Nov 2nd, 2018 - Immunoglobulin light chain amyloidosis (AL) is the most common type of systemic amyloidosis in the United States, with an estimated 12,000 US adults currently living with the condition. Outside of the United States, AA amyloidosis is more common t...

Rely on Colchicine for FMF, Experts Say
https://www.medpagetoday.com/rheumatology/generalrheumatology/55872

Jan 27th, 2016 - Action Points An international group of experts has formulated new recommendations for the management of the autoinflammatory condition known as familial Mediterranean fever, focusing principally on the use of colchicine to prevent both acute atta...

Familial Mediterranean Fever
https://www.medscape.com/viewarticle/450325_1

Abstract and Introduction Background: The pathogenesis of familial Mediterranean fever (FMF) is unknown, and since no specific laboratory test is yet available, the diagnosis of FMF remains clinical. The purpose of this study was to review clinica...

Familial Mediterranean Fever
https://www.medscape.com/viewarticle/450325

Abstract and Introduction Background: The pathogenesis of familial Mediterranean fever (FMF) is unknown, and since no specific laboratory test is yet available, the diagnosis of FMF remains clinical. The purpose of this study was to review clinica...

AL Amyloidosis: Advances in Diagnostics and Treatment
https://www.medscape.com/viewarticle/918626

Abstract and Introduction Abstract AL amyloidosis (light chain; previously also called primary amyloidosis) is a systemic disease characterized by an amyloid deposition process affecting many organs, and which still has unsatisfactory survival of ...

see more →

Patient Education  5 results see all →